Back

Effect of mavacamten on left atrial remodeling and function in obstructive hypertrophic cardiomyopathy. A real-world multicentric prospective study.

29 August 2026 (09:40 - 09:50)
Organised by: Logo
Congress Presentation Part of: Echocardiographic innovation and variability in cardiomyopathy assessment Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nicolas Cohen

APHM La Timone Hospital, Marseille (France)

5 More presentations in this session

Presentation thumbnail
Clinical–core lab discrepancies in echocardiography and their impact on implantable cardioverter-defibrillator eligibility in hypertrophic cardiomyopathy
Ms B. Chen (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Inter-vendor agreement and test-retest reproducibility of right ventricular and left atrial strain measurements using two-dimensional speckle-tracking echocardiography
Doctor A. Balinisteanu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Prognostic correlates of hypercontractile phenotype and left ventricular contractile reserve based on the force
Doctor Q. Ciampi (Benevento, IT)
Abstract Slides Video
Presentation thumbnail
AI-aided echocardiographic quantification improves efficiency across operator experience levels: a prospective clinical trial
Doctor J. Trefny (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis of diagnostic performance of left ventricular strain parameters in cardiac amyloidosis.
Miss S. Bouloukou (Thessaloniki, GR) Assistant Professor E. Pagourelias (Thessaloniki, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Echocardiographic innovation and variability in cardiomyopathy assessment
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 09:40 CET
You may be interested in
thumbnail
Congress Presentation
Effect of Mavacamten on left ventricular diastolic function and left atrial function in obstructive hypertrophic cardiomyopathy
1 September 2025
thumbnail
Congress Presentation
How different types of cardiomyopathy with hypertrophic phenotype affect left atrial remodeling and function
2 September 2024
thumbnail
Congress Presentation
Refining arrhythmic risk stratification in hypertrophic cardiomyopathy through left atrial volume and strain
28 August 2026
thumbnail
Congress Presentation
Favorable effect of aficamten on left atrial mechanics in obstructive hypertrophic cardiomyopathy: insights from the SEQUOIA-HCM trial
9 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources